Molecular mediators of breast cancer metastasis
Breast cancer has the highest incidence rate of malignancy in women worldwide. A major clinical challenge faced by patients with breast cancer treated by conventional therapies is frequent relapse. This relapse has been attributed to the cancer stem cell (CSC) population that resides within the tumo...
Guardado en:
Autores principales: | Ragini Yeeravalli, Amitava Das |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a9ab181f68241d79f6050be0addf87e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EVOLUTION OF THE PLEURAL SECRETOME ASSOCIATED WITH PLEURAL METASTASIS
por: Albert D. Donnenberg, PhD, et al.
Publicado: (2021) -
CAN SERUM KL-6 LEVEL BE USED AS A MARKER IN LUNG METASTASIS OF BONE SARCOMAS?
por: Turan BAYHAN, et al.
Publicado: (2021) -
LEWIS C IN BREAST CANCER PROGRESSION
por: Нина Гадецкая
Publicado: (2021) -
Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma
por: Bhutani D, et al.
Publicado: (2017) -
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis
por: Russell Sterrett, et al.
Publicado: (2021)